Cell-Free DNA in Hereditary and High-Risk Malignancies
common.study.values.description
“Cell-free DNA in Hereditary And High-Risk Malignancies”
The goal of this study is to develop an effective, sensitive blood test that can detect early tumours in patients with known or suspected hereditary cancer syndromes (HCS). If this new blood test is accurate, it could be used to screen patients for cancer and allow for earlier cancer detection. The study will also use questionnaires and interviews to understand how patients feel about incorporating these tests into routine medical care, and the perceptions of the medical value of test results.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-yes
Genetic - Next generation sequencing (NGS)
NGS
participant.views.study.view.additional
participant.views.study.view.scientific-title
Early Detection of Cancer in High-risk Patients Through Cell-free DNA
common.study.values.clinical-trial-id
NCT04261972
participant.views.study.view.id
epYNra
